Faculty Books and Book Chapters

ASHP Guidelines on Pharmacist Involvement in HIV Care

Title

ASHP Guidelines on Pharmacist Involvement in HIV Care

ISBN or ISSN

1079-2082

Publication Date / Copyright Date

2015

First Page

348

Last Page

371

Publisher

Bethesda: American Journal of Health-System Pharmacy

Abstract

The epidemic of human immunodeficiency virus (HIV) infection in the United States has changed dramatically since its initial recognition in 1981.1 Early in the epidemic, the incidence of HIV reached over 130,000 new cases per year, and death as a result of acquired immunodeficiency syndrome (AIDS) was an almost certain prognosis for those infected.2 Significant advances in the strategies to prevent HIV transmission and in the medical care of patients with HIV infection led to significant reductions in both HIV transmission events and AIDS-related deaths over time. Among these advancements were an understanding of HIV infection pathophysiology, identification of HIV transmission modes, development of public health interventions targeting behavioral changes in high-risk populations, and identification of novel HIV medication targets leading to advances in HIV treatment and eventually combination antiretroviral therapy (ART).

Comments

Citation details to be verified.

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Keywords

HIV care, pharmacist involvement, pharmacology

Files

ASHP Guidelines on Pharmacist Involvement in HIV Care

Share

 
COinS